MCRB
Seres Therapeutics Inc
NASDAQ: MCRB · HEALTHCARE · BIOTECHNOLOGY
$7.05
-0.56% today
Updated 2026-04-29
Market cap
$67.91M
P/E ratio
11.02
P/S ratio
86.07x
EPS (TTM)
$0.64
Dividend yield
—
52W range
$7 – $30
Volume
0.1M
WallStSmart proprietary scores
35
out of 100
Grade: D
Sell
Investment rating
2.0
Growth
F5.0
Quality
C+5.5
Profitability
C+6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-12.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$22.00
+212.06%
12-Month target
$7.31
+3.69%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 722.00% — above average
Risks
- Altman Z -11.96 — distress zone
- Negative free cash flow $-14.74M
- Revenue declining -93.40% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $7.13M | $126.33M | $0.00 | $789000.00 | $789000.00 |
| Net income | $-250.16M | $-113.72M | $136000.00 | $5.70M | $-15.34M |
| EPS | — | — | — | — | $0.64 |
| Free cash flow | $-238.64M | $-125.33M | $-148.99M | $865000.00 | $-14.74M |
| Profit margin | -3,509.50% | -90.02% | — | 721.93% | 722.00% |
Peer comparison
Smart narrative
Seres Therapeutics Inc trades at $7.05. representing a P/E of 11.02x trailing earnings. Our Smart Value Score of 35/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -11.96, it sits in the distress. TTM revenue stands at $789000.00. with profit margins at 722.00%.
Frequently asked questions
What is Seres Therapeutics Inc's stock price?
Seres Therapeutics Inc (MCRB) trades at $7.05.
Is Seres Therapeutics Inc overvalued?
Smart Value Score 35/100 (Grade D, Sell).
What is the price target of Seres Therapeutics Inc (MCRB)?
The analyst target price is $22.00, representing +212.1% upside from the current price of $7.05.
What is Seres Therapeutics Inc's revenue?
TTM revenue is $789000.00.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-11.96 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio86.07x
ROE19.60%
Beta0.26
50D MA$8.70
200D MA$14.56
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—